The Pharmacy Vaccinations Development Group (PVDG)
About the PVDG
The Pharmacy Vaccinations Development Group (PVDG) provides a dedicated forum for stakeholders involved in the design, manufacture, commissioning, and provision of vaccination programmes. The group’s sole purpose is to improve access and uptake of vaccines across Great Britain. The group is working to establish the model for commissioning, promoting, and delivering vaccination programmes in community pharmacy.
Objectives
The objectives of the group are to:
- Enhance access to the covid vaccine programme by including more pharmacies as the programme continues to move to ‘business as usual’ (i.e., a routine part of NHS vaccination programmes, rather than a unique time limited programme).
- Raise awareness amongst decision makers as to the potential role of community pharmacy in increasing access to vaccines.
- Advocate for the expansion of the vaccine offer to patients through additional NHS commissioned services in pharmacies.
- Investigate (and if required collect) data from current community pharmacy vaccine programmes to highlight impact on uptake/access/inequalities.
- Facilitate the introduction of new vaccines into the NHS.
Sponsorship
The PVDG is funded as part of a sponsorship agreement with its corporate members. The Group is currently funded is currently sponsored by GSK, MSD, Pfizer UK and Viatris.
Membership
Members of the PVDG include representatives from AAH, Asda, Alliance Healthcare, Boots, National Pharmacy Association (NPA), Numark, Pharmacy2U, Phoenix Medical, Rowlands Pharmacy, Royal Pharmaceutical Society, Superdrug, Tesco, and Well.
The group is also attended by representatives from NHSE, DHSC, UKHSA, and GPhC.
Joining the PVDG
If your organisation would like to attend PVDG or sponsor the work, please contact the CCA at [email protected]
The Company Chemists’ Association provides the secretariat support to the PVDG.